In the past, artificial intelligence (AI) in healthcare was mostly in the hands of specialists — experts in marrying supercomputers to hefty hospital devices. Now, thanks to a new breed of compact, handheld AI-assisted disease-detection devices, that is changing. Healthcare AI is increasingly in the hands (and the pockets) of non-specialists.
Lightweight, battery-powered handheld healthcare AI devices made a splash in January 2024 with the arrival of a portable device for detecting skin cancer. Approved for marketing by the US Food and Drug Administration (FDA) under the brand name DermaSensor, the device looks like an oversized cellphone. It is approved for use solely by physicians, and only in patients over 40 years of age, to help in the evaluation of skin lesions suggestive of three types of skin cancer: melanoma, basal cell carcinoma and squamous cell carcinoma… Continue reading.